医学全在线
医学全在线首页-开云app安装不了怎么办 -药师-护士-卫生资格-高级职称-考试题库-网校-考研-图谱-下载-招聘  
分类
国家级省级浙江省各省杂志
科技核心北大核心CSCDCSCD扩展
工具
期刊知识写作指导 论文投稿推荐期刊
期刊验证论文检测 录用通知往期目录
SCI
SCI指导影响因子
期刊点评基金动态
其它
经济教育计算机
建筑体育农业
北京|天津|河北|山西|湖北|江苏|安徽|山东|上海|浙江|江西|福建|湖南|宁夏|内蒙古|河南
四川|重庆|贵州|云南|辽宁|吉林|广东|广西|海南|陕西|甘肃|新疆|青海|卫生部直属|黑龙江|兵团
您现在的位置: 医学全在线 > 医学论文 > SCI期刊 > 正文:ADVANCES IN HUMAN GENETICS if:ADVANCES IN HUMAN GENETICS
    

ADVANCES IN HUMAN GENETICS


ADVANCES IN HUMAN GENETICS
影响因子:
I S S N: 0065-275X
出 版 社: Advances in human genetics
出 版 地: R Drouin
出版国家: American
刊  期: 0
创刊时间: 1994
语  种: 英文
审稿周期:
中科院分区:
投稿命中率: 容易
国外数据库收录: IM
中国收录文章数:
5年影响因子:
研究领域: 遗传学
官方链接: http://www.researchgate.net/journal/0065-275X_Adva...
投稿须知: http://www.researchgate.net/journal/0065-275X_Adva...

期刊介绍:

In the Journal of human genetics, we celebrate the first chapter we focus onrecent advances in pharmacogenomics: Study of genetic variability in drug response effect.

In the past ten years, considerable progress has been made in the human genome research, analysis of the international scientific research infrastructure technology and human genome information in the two genomes progress. In particular, genome-wide association studies have found thousands of associated with disease susceptibility and drug response of genetic variation. These findings raise the mechanism of pathogenesis and drug reaction related to ourunderstanding of disease. In addition, the genetic background of this knowledgehas been revealed, contribute to the differences in disease susceptibility andindividual drug reaction between.

The next step is to transform the results into clinical practice. A great influence on some have identified genetic variation, and highly accurate prediction of drug response. Therefore, such "pharmacogenomic markers" are candidates todetermine which patients will benefit from a specific drug. This special sectioncontains eight of pharmacogenomics in clinical research and the current status of the implementation of.

Focus of cancer pharmacogenomics is 5 comments. A rough outline of theinfluence of Hertz and Macleod provide genomic changes related to cancer therapy. They stressed the importance of genetic variation is a cancer patient's prognosis, response, toxicity and exposure forecast example. ICAS described inpharmacogenomics of endocrine therapy for breast cancer. His review revealsthe power of genome-wide association studies, find out the key genes influencing drug response, importance and function study is to elucidate the mechanism of drug response. The key scientific problem research in pharmacogenomics of endocrine therapy for breast cancer by Kiyotani et al. Further discussion. , whofocused on the controversial variants found in evaluation of CYP2D6 reaction to the drug tamoxifen effect. In the study, Chi et al found in the importance and difficulty of entailed blood cancer pharmacogenomics research. In addition, black stone, Yagi and pharmaceuticals and Medical Devices Agency Yu Shan, Japan,regulators to examine the usefulness and pharmacogenomics instruction the limitations of clinical trials in Japan approved anticancer drugs.

Two major adverse drug reaction, drug genome study of cutaneous adverse reactions and drug-induced liver injury serious study, summed up the Kaniwa and Saito. This paper reviews the HLA allele is an important contribution to thephenotype.

Klein and Lee to review progress, and challenges, facing the implementation ofHua Falin, a clinical drug genome as everyone knows anticoagulant studies. In addition, Perry and Shuldiner discuss variants of CYP2C19 and pharmacokinetics and pharmacodynamics, the relationship between clinicalresponse and anti clotting drug clopidogrel in relatively new.

...
关于我们 - 联系我们 -版权申明 -诚聘英才 - 网站地图 - 网络课程 - 帮助
医学全在线 版权所有© CopyRight 2006-2046,
浙ICP备12017320号
百度大联盟认证绿色会员实名网站 360认证可信网站 中网验证
Baidu
map